** SI-BONE Inc's SIBN.O shares down 6.8% at $22.80
premarket after medical device firm's overnight follow-on prices
** Co late Thurs announced ~3.8 mln shares at $22, 10.1%
discount to last sale
** SIBN offering ~3.5 mln shares and board chairman Jeffrey
Dunn selling the balance of approx 273k, per the prospectus
filing
** Co plans to use net offering proceeds it receives for
product innovation, clinical evidence, build implants and
surgical instrument systems, and other purposes
** With ~35.2 mln shares outstanding, SIBN has ~$861 mln
market cap
** Shares have gained 80% YTD through Thurs close
** BofA, Morgan Stanley and Jefferies acting as joint
book-running managers on the offering
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-646-279-6380))